Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1859 participants.
Also called NCT07258290
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,859 participants
- Sponsor
- Registry
-
NCT07258290
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, France, Latvia, Poland
- Registry status
- Recruiting
Technical summary
Registry record NCT07258290. Randomized; single masking; primary purpose treatment. Start 2026-06-11 (actual); primary completion 2029-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
- Acronym
- BIOMAG-III
- Condition
- Coronary Disease
- Condition
- Heart Diseases
- Condition
- Cardiovascular Diseases
- Condition
- Arteriosclerosis
- Condition
- Arterial Occlusive Diseases
- Condition
- Vascular Diseases
- Condition
- Chest Pain
- Condition
- Pain
- Condition
- Neurologic Manifestations
- Condition
- Signs and Symptoms
- Condition
- Pathological Conditions, Signs and Symptoms
- Condition
- Coronary Artery Disease
- Condition
- Myocardial Ischemia
- Condition
- Acute Coronary Syndrome
- Condition
- Angina Pectoris
- Intervention (Device)
- Freesolve RMS
- Intervention (Device)
- Xience DES
- Lead sponsor
- Teleflex
Record details
- Record id
cardio:ct-nct07258290- Content hash
2cebe5f46b5480025e67123fe85d1f4ede870bfe38fe76b041649a33f52e95c3